Skip to main content
TipRanks
Go Ultimate75% OFF

Apollo Hospitals Enterprise Limited (APOLLOHOSP) AI Stock Analysis

11 Followers
IN:APOLLOHOSP

Apollo Hospitals Enterprise Limited

(NSE:APOLLOHOSP)

Select Model
Rating:59Neutral
Price Target:INR 8,151.00â–¼(-4.28% Downside)
Action:reiterated
Date:08/24/26

The score is supported primarily by improving fundamentals (faster revenue growth, expanding margins, and strong ROE), but is held back by premium valuation (high P/E and low yield) and weaker near-term technicals (negative MACD and price below short-term moving averages).

Positive Factors
Accelerating Revenue GrowthThe return to stronger revenue growth after a weak 2025 suggests improving demand and operating momentum across Apollo’s healthcare platform. Sustained top-line expansion can support greater network utilization, strengthen scale benefits, and provide a durable base for future earnings growth.
Negative Factors
Rising LeverageDebt approaching the level of equity reduces financial flexibility and increases the importance of maintaining strong hospital utilization and pricing. Rising leverage can constrain future investment choices, increase financing sensitivity, and make earnings more vulnerable if operating conditions weaken.

Apollo Hospitals Enterprise Limited (APOLLOHOSP) vs. iShares MSCI India ETF (INDA)

-20%-10%0%10%20%30%IN:APOLLOHOSP+15.61%INDA-5.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 1.23T
Dividend Yield
0.23%
Average Volume (3M)
37.54K
Price to Earnings (P/E)
54.7
Beta (1Y)
0.72
Revenue Growth
19.24%
EPS Growth
34.11%
Country
India
Employees
44,008
Sector
General
Sector Strength
55
Industry
Medical - Care Facilities

Apollo Hospitals Enterprise Limited Business Overview & Revenue Model

Company Description

Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care....

How the Company Makes Money

Apollo Hospitals Enterprise Limited primarily generates revenue by delivering healthcare services across its hospital network and related healthcare businesses. Key revenue streams include: (1) Hospital services: Income from inpatient and outpatient...

Apollo Hospitals Enterprise Limited Financial Statement Overview

Summary

Strong 2026 acceleration in revenue growth (+8.4%) with improving profitability (net margin ~7.7%, operating margin ~11.5%) and higher ROE (~20.5%). Offsets are moderately high and rising leverage (debt-to-equity ~0.90) plus weaker and choppier cash conversion (FCF ~27% of net income and volatility in recent years).

Income Statement

76Positive

Balance Sheet

70Positive

Cash Flow

62Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue277.41B252.28B217.94B190.59B166.13B146.63B
Gross Profit105.13B82.77B73.50B63.98B56.68B51.31B
EBITDA41.31B39.87B30.33B23.94B20.65B21.89B
Net Income22.42B19.42B14.46B8.99B8.19B10.56B
Balance Sheet
Total Assets242.22B221.97B206.57B167.53B144.28B131.92B
Cash, Cash Equivalents and Short-Term Investments23.81B21.33B27.93B11.89B7.26B10.48B
Total Debt81.49B84.93B78.64B53.33B43.32B40.68B
Total Liabilities130.65B122.22B120.05B94.33B78.96B73.15B
Stockholders Equity106.04B94.80B82.12B69.35B61.97B56.23B
Cash Flow
Free Cash Flow07.12B2.16B7.83B2.49B9.71B
Operating Cash Flow026.74B19.29B19.20B13.77B16.28B
Investing Cash Flow0-22.44B-34.77B-15.37B-8.71B-8.47B
Financing Cash Flow0-2.00B16.21B-3.11B-6.33B-7.93B

Apollo Hospitals Enterprise Limited Technical Analysis

Technical Analysis SentimentPositive
Last Price8515.50

Price Trends

50DMA8376.32Positive
100DMA8586.11Negative
200DMA8144.13Positive

Market Momentum

MACD91.46Negative
RSI58.16Neutral
STOCH66.76Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:APOLLOHOSP, the sentiment is Positive. The current price of 8515.50 is above the 20-day moving average (MA) of 8160.78, above the 50-day MA of 8376.32, and above the 200-day MA of 8144.13, indicating a bullish trend. The MACD of 91.46 indicates Negative momentum. The RSI at 58.16 is Neutral, neither overbought nor oversold. The STOCH value of 66.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:APOLLOHOSP.

Apollo Hospitals Enterprise Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:APOLLOHOSP against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:MEDANTAIN:MEDANTA79OutperformINR 390.83B63.16―0.07%26.18%10.09%
IN:NHIN:NH67NeutralINR 380.62B44.06―0.24%71.40%1.76%
IN:MAXHEALTHIN:MAXHEALTH63NeutralINR 919.79B66.79―0.21%15.17%1.63%
IN:APOLLOHOSPIN:APOLLOHOSP59NeutralINR 1.22T54.67―0.23%19.24%34.11%
IN:FORTISIN:FORTIS59NeutralINR 577.54B55.52―0.13%17.50%2.40%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:ASTERDMIN:ASTERDM55NeutralINR 629.52B99.93―0.55%50.47%10.73%

* General Sector Average

Performance Comparison

-20%0%20%IN:APOLLOHOSPIN:ASTERDMIN:FORTISIN:MAXHEALTHIN:MEDANTAIN:NHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:APOLLOHOSP and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:APOLLOHOSPApollo Hospitals Enterprise Limited8515.501045.7314.00%
IN:ASTERDMAster DM Healthcare Ltd.722.2043.856.46%
IN:FORTISFortis Healthcare Ltd.765.00-178.15-18.89%
IN:MAXHEALTHMax Healthcare Institute Ltd945.00-174.91-15.62%
IN:MEDANTAGlobal Health Limited1453.55249.7820.75%
IN:NHNarayana Hrudayalaya Ltd.1862.50-160.90-7.95%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 24, 2026